Boston Scientific Corporation (NYSE: BSX) has received Food and Drug Administration (FDA) approval for the Innova™ Vascular Self-Expanding Stent System, an advanced treatment option for patients with ...

NATICK, Mass., Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the ...

Boston Scientific's FDA-approved Innova stent for PAD--Courtesy of Boston Scientific Boston Scientific ($BSX) announced FDA approval of its Innova Vascular Self ...

Innovative Stent Designed to Treat Peripheral Vascular Lesions for Stenoses in Arteries above the Knee NATICK, Mass., Boston Scientific Corporation announces CE Mark and European market launch of the ...

Medical device major Boston Scientific Corporation 's BSX self-expanding stent system - Innova Vascular - recently won marketing approval from the U.S. Food and Drug Administration (FDA). Subsequent ...

The launch of the Innova stent will be of immense benefit to several patients as, according to estimates in Europe, Peripheral vascular disease (“PVD”) affects 13 million people or one in 20 people ...

Boston Scientific Corp. on Monday announced CE Mark approval and the European market launch of its Innova Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions ...

Please provide your email address to receive an email when new articles are posted on . A primary patency rate of more than 70% was reported in a cohort of patients who received drug-eluting balloons ...

Please provide your email address to receive an email when new articles are posted on . Among patients who had endovascular revascularization of the superficial femoral artery, stent thrombosis ...

NATICK, Mass., Oct. 9, 2013 /PRNewswire/ -- Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the ...

Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston ...